Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 5 (2008), Issue 6 (June)

1. ROCK, PAK, and Toll of synapses in Alzheimer's disease.
   Biochem Biophys Res Commun, 371(4): 587-90. [Abstract] [Full-text]
2. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
   Neurology, 70(23): 2219-25. [Abstract] [Full-text]
3. VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study.
   Neurology, 70(23): 2201-11. [Abstract] [Full-text]
4. An aberrant protein complex in CSF as a biomarker of Alzheimer disease.
   Neurology, 70(23): 2212-8. [Abstract] [Full-text]
5. Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide.
   Proteins, 72(1): 1-24. [Abstract] [Full-text]
6. Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model.
   Proc Natl Acad Sci U S A, 105(22): 7863-8. [Abstract] [Full-text]
7. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study.
   Arch Neurol, 65(6): 790-5. [Abstract] [Full-text]
8. Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.
   Arch Neurol, 65(6): 776-85. [Abstract] [Full-text]
9. No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.
   Neurology, 70(24): 2291-8. [Abstract] [Full-text]
10. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease.
    J Neurosci, 28(24): 6174-81. [Abstract] [Full-text]
11. High content analysis of gamma-secretase activity reveals variable dominance of presenilin mutations linked to familial Alzheimer's disease.
    Biochim Biophys Acta, 1783(8): 1551-60. [Abstract] [Full-text]
12. The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.
    J Biol Chem, 283(25): 17039-48. [Abstract] [Full-text]
13. Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.
    Free Radic Biol Med, 45(3): 219-30. [Abstract] [Full-text]
14. Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.
    J Neurosci, 28(25): 6388-92. [Abstract] [Full-text]
15. Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer's disease.
    Clin Pharmacol Ther, 84(1): 63-8. [Abstract] [Full-text]
16. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease.
    J Pharmacol Exp Ther, 326(1): 196-208. [Abstract] [Full-text]
17. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.
    Radiology, 248(1): 210-20. [Abstract] [Full-text]
18. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus.
    Radiology, 248(1): 194-201. [Abstract] [Full-text]
19. Increased expression of the oligopeptidase THOP1 is a neuroprotective response to Abeta toxicity.
    Neurobiol Dis, 31(1): 145-58. [Abstract] [Full-text]
20. Animal models of Alzheimer's disease and frontotemporal dementia.
    Nat Rev Neurosci, 9(7): 532-44. [Abstract] [Full-text]
21. A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment.
    Neurobiol Dis, 31(1): 46-57. [Abstract] [Full-text]
22. Double stranded RNA activated EIF2 alpha kinase (EIF2AK2; PKR) is associated with Alzheimer's disease.
    Neurobiol Aging, 29(8): 1160-6. [Abstract] [Full-text]
23. Psychosis of Alzheimer's disease: Gender differences in regional perfusion.
    Neurobiol Aging, 29(8): 1218-25. [Abstract] [Full-text]
24. Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
    Neurobiol Aging, 29(8): 1190-8. [Abstract] [Full-text]
25. PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD.
    Neurobiol Aging, 29(8): 1204-17. [Abstract] [Full-text]
26. Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging.
    Neurobiol Aging, 29(8): 1199-203. [Abstract] [Full-text]
27. A SNP in the ACT gene associated with astrocytosis and rapid cognitive decline in AD.
    Neurobiol Aging, 29(8): 1167-76. [Abstract] [Full-text]
28. Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.
    Neuron, 58(6): 871-83. [Abstract] [Full-text]
29. Network analysis of intrinsic functional brain connectivity in Alzheimer's disease.
    PLoS Comput Biol, 4(6): e1000100. [Abstract] [Full-text]
30. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
    Cell, 133(7): 1149-61. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.